Treosulfan–fludarabine–thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignancies
Krzysztof Kałwak(Poznan University of Medical Sciences), Ajay Vora(Great Ormond Street Hospital), Ingo Müller(Universität Hamburg), Katarzyna Drabko(Medical University of Lublin), Bernd Gruhn(Jena University Hospital), Franco Locatelli(Bambino Gesù Children's Hospital), Monika Mielcarek‐Siedziuk(Wroclaw Medical University), Peter Bader(Goethe University Frankfurt), Jolanta Goździk(Jagiellonian University), Klaus Daniel Stachel(Universitätsklinikum Erlangen), Joachim Baumgart(Medac (Germany)), Birgit Burkhardt(University Hospital Münster), Johann Greil(German Center for Pediatric and Adolescent Rheumatology), Franca Fagioli(Ospedale Regina Margherita), Selim Corbacioglu(Unknown), Claudia Hemmelmann(University of Lübeck), Jan Styczyński(Nicolaus Copernicus University), Petr Sedláček(University Hospital in Motol), Katharine Patrick(Sheffield Children's NHS Foundation Trust), Karl W. Sykora(Medizinische Hochschule Hannover), Rita Beier(Medizinische Hochschule Hannover), Paul G. Schlegel(Goethe University Frankfurt), Ann-Kristin Möller(Medac (Germany))
Cited by 35
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
|New England Journal of Medicine|2020|1.8k
Rational Extended Thermodynamics
|Springer Tracts in Natural Philosophy|1998|1.3k
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k